UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

A promising preclinical model for TERT promoter mutation in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-12, Vol.24 (12), p.2076-2077

Huse, Jason T

2022

Link zum Volltext

Verfügbarkeit prüfen

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update

Brain pathology (Zurich, Switzerland), 2022-07, Vol.32 (4), p.e13062-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021

Current neurology and neuroscience reports, 2021-12, Vol.21 (12), p.67-67, Article 67

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Neuro-oncology (Charlottesville, Va.), 2017-08, Vol.19 (8), p.1047-1057

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular subclassification of diffuse gliomas: Seeing order in the chaos

Glia, 2011-08, Vol.59 (8), p.1190-1199

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular markers and targeted therapy in pediatric low-grade glioma

Journal of neuro-oncology, 2020-10, Vol.150 (1), p.5-15

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas

Brain pathology (Zurich, Switzerland), 2013-09, Vol.23 (5), p.558-564

2013

Link zum Volltext

Verfügbarkeit prüfen

Multinodular and Vacuolating Neuronal Tumors of the Cerebrum: 10 Cases of a Distinctive Seizure-Associated Lesion

Brain pathology (Zurich, Switzerland), 2013-09, Vol.23 (5), p.515-524

2013

Link zum Volltext

Verfügbarkeit prüfen

Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true “oligoastrocytoma”?

Acta neuropathologica, 2015, Vol.129 (1), p.151-153

2015

Link zum Volltext

Verfügbarkeit prüfen

Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing

Brain pathology (Zurich, Switzerland), 2009-01, Vol.19 (1), p.132-143

2009

Link zum Volltext

Verfügbarkeit prüfen

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Neuro-oncology (Charlottesville, Va.), 2016-04, Vol.18 (4), p.557-564

2016

Link zum Volltext

Verfügbarkeit prüfen

Survival in patients treated for anaplastic meningioma

Journal of neurosurgery, 2015-07, Vol.123 (1), p.23-30

2015

Link zum Volltext

Verfügbarkeit prüfen

Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma

Neuro-oncology (Charlottesville, Va.), 2024-01, Vol.26 (1), p.55-67

2024

Link zum Volltext

Verfügbarkeit prüfen

Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas

Journal of neuropathology and experimental neurology, 2018-06, Vol.77 (6), p.437-442

2018

Link zum Volltext

Verfügbarkeit prüfen

A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma

Journal of neuropathology and experimental neurology, 2018-11, Vol.77 (11), p.1039-1054

2018

Link zum Volltext

Verfügbarkeit prüfen

TERT promoter mutation designates biologically aggressive primary glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-01, Vol.17 (1), p.5-6

Huse, Jason T

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease

Journal of neuropathology and experimental neurology, 2018-07, Vol.77 (7), p.628-635

2018

Link zum Volltext

Verfügbarkeit prüfen

Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma

The Journal of neuroscience, 2023-11, Vol.43 (47), p.8043

2023

Link zum Volltext

Verfügbarkeit prüfen

An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation

Journal of neuropathology and experimental neurology, 2024-02, Vol.83 (2), p.139-141

2024

Link zum Volltext

Verfügbarkeit prüfen

Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis

Acta neuropathologica, 2021-02, Vol.141 (2), p.303-321

2021

Link zum Volltext

Verfügbarkeit prüfen

Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort

Neuro-oncology (Charlottesville, Va.), 2020-04, Vol.22 (4), p.450-456

2020

Link zum Volltext

Verfügbarkeit prüfen

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients

Neuro-oncology (Charlottesville, Va.), 2019-12, Vol.21 (12), p.1498-1508

2019

Link zum Volltext

Verfügbarkeit prüfen

Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma

Neuropathology, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics

Neuro-oncology (Charlottesville, Va.), 2023-02, Vol.25 (2), p.398-406

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A promising preclinical model for TERT promoter mutation in glioblastoma

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Molecular subclassification of diffuse gliomas: Seeing order in the chaos

Molecular markers and targeted therapy in pediatric low-grade glioma

Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas

Multinodular and Vacuolating Neuronal Tumors of the Cerebrum: 10 Cases of a Distinctive Seizure-Associated Lesion

Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true “oligoastrocytoma”?

Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Survival in patients treated for anaplastic meningioma

Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma

Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas

A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma

TERT promoter mutation designates biologically aggressive primary glioblastoma

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease

Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma

An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation

Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis

Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients

Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma

Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics

Aktive Filter

Suchergebnisse filtern